Chemesis International Inc. Provides Corporate Update
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. Provides Corporate Update
October 23, 2019
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), announces that, alongside several other companies operating in Puerto Rico, certain of the
cannabis licenses (“Licenses”) held by its subsidiary, Natural Ventures PR, LLC (“ Natural Ventures”), are
currently subject to an administrative review (“Review”) being undertaken by the Puerto Rico Department
of He alth. The Company expects this review to be concluded promptly, and notes that its permitted
activities under the License are limited until the Review has concluded.
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi -State operator with International
operations in Puerto Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it maintains a fir st mover advantage as it
enters new markets and is committed to differentiate itself by deploying resources in markets with major
opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis
consumers, with focus on quality and consistency.
Chemesis has facilities in both Puerto Rico and California and is in the process of constructing a GMP
certified facility in Colombia. Chemesis’ Puerto Rico operations are licensed to operate 100,000 ft 2 of
cultivation, and 35,0 00 ft 2 of manufacturing floor space. The Company is positioned to win additional
licenses in highly competitive merit-based US states and will expand its footprint to ensure it maintains a
first mover advantage.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
GreenSpiritRX
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of
applicable securities laws relating to statements regarding the Company's business, products and future of the
Company’s business, its product offerings and plans for sales and marketing, including with respect to the Company’s
expectations regarding the Review, its plans to continue to develop dispensaries in Puerto Rico, and its ability to
obtain licenses in additional jurisdictions. Although the Company believes that the expe ctations reflected in the
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
forward-looking information are reasonable, there can be no assurance that such expectations will prove to be
correct. Readers are cautioned not to place undue reliance on forward -looking information. Such forward -looking
statements are subject to risks and uncertainties that may cause actual results, performance and developments to
differ materially from those contemplated by these statements depending on, among other things, the risks that the
Review may not be completed promptly , that the activities permitted under the Licenses will be restored, that the
Company's products and plan will vary from those stated in this news release and the Company may not be able to
carry out its business plans as expected, including, but not limited to, in relation to developing dispensaries in Puerto
Rico, and its ability to obtain licenses in additional jurisdictions. Except as required by law, the Company expressly
disclaims any obligation and does not intend to update any forward -looking statem ents or forward -looking
information in this news release. Although the Company believes that the expectations reflected in the forward -
looking information are reasonable, there can be no assurance that such expectations will prove to be correct and
makes no reference to profitability based on sales reported. The statements in this news release are made as of the
date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release